<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18027/2224-5057-2011-1-29-39</article-id><article-id custom-type="elpub" pub-id-type="custom">tumors-142</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ КОНФЕРЕНЦИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURE</subject></subj-group></article-categories><title-group><article-title>Почечно-клеточный рак у пациентов, находящихся на диализе</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ISHIKAWA</surname><given-names>ISAO</given-names></name></name-alternatives><email xlink:type="simple">isikawai@kanazawa-med.ac.jp</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Isao Ishikawa, Division of Nephrol- ogy, Department of Internal Medicine, Asanogawa General Hospital, 83 KosakaNaka, Kanazawa, 920-8621, Ishikawa, Japan. Tel. +81 76-252-2101</institution><country>Japan</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>03</day><month>08</month><year>2015</year></pub-date><volume>1</volume><issue>1</issue><fpage>29</fpage><lpage>39</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; ISHIKAWA I., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">ISHIKAWA I.</copyright-holder><copyright-holder xml:lang="en">ISHIKAWA I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/142">https://www.malignanttumors.org/jour/article/view/142</self-uri><abstract><p>Заболеваемость почечно-клеточным раком (ПКР) у пациентов, находящихся на диализе, выше, чем в общей популяции. Чем дольше больной получает гемодиализ, тем выше заболеваемость ПКР. Риск развития ПКР связан с формированием поликистоза почек. Некоторые виды ПКР у пациентов, находящихся на гемодиализе, или пациентов с заболеваниями почек поздних стадий не соответствуют гистологической классификации ПКР, представленной Всемирной Организацией Здравоохранения. Такие опухоли отличаются от спорадических; их называют ПКР, ассоциированным с приобретенным поликистозом почек (ППКП), или светлоклеточным-папиллярным ПКР у пациентов с заболеваниями почек поздних стадий. Рак почки на фоне ППКП развивается у пациентов, которые получают диализ длительно (более 10 лет). В связи с высокой заболеваемостью и отсутствием симптомов, пациентов находящихся на диализе из группы высокого риска, необходимо обследовать на предмет ПКР. Такой скрининг особенно важен для пациентов на диализе продолжительностью более 10 лет, пациентам с тяжелым ППКП и кандидатам на трансплантацию почки. Опухоль в почке, прилежащая к множественным приобретенным кистам, как правило, мало или совсем не накапливает контрастное вещество при КТ, а также не выступает за контур почки. Таким образом, дооперационная оценка ПКР у пациентов на длительном диализе затруднительна. </p></abstract><kwd-group xml:lang="ru"><kwd>приобретенные кисты почек</kwd><kwd>гемодиализ</kwd><kwd>почечно-клеточный рак</kwd><kwd>ПКР на фоне ППКП</kwd><kwd>ультразвуковое исследование с контрастированием с использованием перфторбутановых микропузырьков</kwd><kwd>ПЭТ-КТ</kwd><kwd>КТ. </kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Acquired Cystic Disease of the Kidney and Renal Cell Carcinoma-Complication of Long-Term Hemodialysis, Springer ,Tokyo. 1-111, 2007</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Acquired Cystic Disease of the Kidney and Renal Cell Carcinoma-Complication of Long-Term Hemodialysis, Springer ,Tokyo. 1-111, 2007</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Saito Y, Onouchi Z, Kitada H, Suzuki S, Kurihara S, Yuri T, Shinoda A: Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients. Clin Nephrol 14: 1-6, 1980</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Saito Y, Onouchi Z, Kitada H, Suzuki S, Kurihara S, Yuri T, Shinoda A: Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients. Clin Nephrol 14: 1-6, 1980</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Onouchi Z, Saito Y, Tateishi K, Shinoda A, Suzuki S, Kitada H, Sugishita N, Fukuda Y: Sex differences in acquired cystic disease of the kidney on long-term dialysis. Nephron 39: 336-340, 1985</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Onouchi Z, Saito Y, Tateishi K, Shinoda A, Suzuki S, Kitada H, Sugishita N, Fukuda Y: Sex differences in acquired cystic disease of the kidney on long-term dialysis. Nephron 39: 336-340, 1985</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Hayama S, Morita K, Nakazawa T, Yokoyama H, Honda R, Satoh K, Kakuma T: Long-term natural history of acquired cystic disease of the kidney. Ther Apher Dial: 14:409-416, 2010</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Hayama S, Morita K, Nakazawa T, Yokoyama H, Honda R, Satoh K, Kakuma T: Long-term natural history of acquired cystic disease of the kidney. Ther Apher Dial: 14:409-416, 2010</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M, Honda R: Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol 59: 153-159, 2003</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M, Honda R: Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol 59: 153-159, 2003</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Uremic acquired cystic disease of kidney. Urology 26: 101-108, 1985</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Uremic acquired cystic disease of kidney. Urology 26: 101-108, 1985</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Present status of renal cell carcinoma in dialysis patients :A questionnaire study in 2004 and review of past questionnaires since 1982 (in Japanese with English abstract). J Jpn Soc Dial Ther 38: 1689-1700, 2005</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Present status of renal cell carcinoma in dialysis patients :A questionnaire study in 2004 and review of past questionnaires since 1982 (in Japanese with English abstract). J Jpn Soc Dial Ther 38: 1689-1700, 2005</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Present status of acquired cystic disease of the kidney (in Japanese). J Jpn Ass Dial Physicians 23: 179-187, 2008</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Present status of acquired cystic disease of the kidney (in Japanese). J Jpn Ass Dial Physicians 23: 179-187, 2008</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dunnill MS, Millard PR, Oliver D: Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J. Clin. Pathol. 30: 868-877, 1977</mixed-citation><mixed-citation xml:lang="en">Dunnill MS, Millard PR, Oliver D: Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J. Clin. Pathol. 30: 868-877, 1977</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hughson MD, Hennigar GR, McManus JFA: Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys. Lab. Invest. 42: 475-480, 1980</mixed-citation><mixed-citation xml:lang="en">Hughson MD, Hennigar GR, McManus JFA: Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys. Lab. Invest. 42: 475-480, 1980</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Eble IN, Sauter G, Epstein JI, al. e: WHO classification of tumours. In: Pathology and Genetics:Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press. 2004</mixed-citation><mixed-citation xml:lang="en">Eble IN, Sauter G, Epstein JI, al. e: WHO classification of tumours. In: Pathology and Genetics:Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press. 2004</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Kovacs G: High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 22: 135-139, 1993</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Kovacs G: High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 22: 135-139, 1993</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Shinoda A: Renal adenocarcinoma with or without acquired cysts in chronic hemodialysis patients. Clin Nephrol 20: 321-322, 1983</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Shinoda A: Renal adenocarcinoma with or without acquired cysts in chronic hemodialysis patients. Clin Nephrol 20: 321-322, 1983</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Prognosis in dialysis patients complicated with renal cell carcinoma (in Japanese with English abstract). J Jpn Ass Soc Dial Ther 35: 287-293, 2002</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Prognosis in dialysis patients complicated with renal cell carcinoma (in Japanese with English abstract). J Jpn Ass Soc Dial Ther 35: 287-293, 2002</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract 97: c11-16, 2004</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract 97: c11-16, 2004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Yuri T, Kitada H, Shinoda A: Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol 3: 310-314, 1983</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Yuri T, Kitada H, Shinoda A: Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol 3: 310-314, 1983</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Truong LD: Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29: 443-451, 2005</mixed-citation><mixed-citation xml:lang="en">Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Truong LD: Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29: 443-451, 2005</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB: Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30: 141-153, 2006</mixed-citation><mixed-citation xml:lang="en">Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB: Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30: 141-153, 2006</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y: Renal cell carcinoma in patients with endstage renal disease: relationship between histological type and duration of dialysis. BJU Int, 2009</mixed-citation><mixed-citation xml:lang="en">Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y: Renal cell carcinoma in patients with endstage renal disease: relationship between histological type and duration of dialysis. BJU Int, 2009</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zamin-Khamesh N, Zhai Q, Truong LD: Renal cell carcinoma with calcium oxalate deposition A distinct type of renal cell carcinoma within the spectrum of renal neoplasms associated with acquired cystic kidney disease. Pathology Case Reviews 15: 14-19, 2010</mixed-citation><mixed-citation xml:lang="en">Zamin-Khamesh N, Zhai Q, Truong LD: Renal cell carcinoma with calcium oxalate deposition A distinct type of renal cell carcinoma within the spectrum of renal neoplasms associated with acquired cystic kidney disease. Pathology Case Reviews 15: 14-19, 2010</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L: Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 19: 780-787, 2006 22. Pan CC, Chen YJ, Chang LC, Chang YH, Ho DM: Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 55: 145-153, 2009</mixed-citation><mixed-citation xml:lang="en">Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L: Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 19: 780-787, 2006 22. Pan CC, Chen YJ, Chang LC, Chang YH, Ho DM: Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 55: 145-153, 2009</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Japanese Urological Association, Japanese Society of Pathology, Japan-Radiological-Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma (in Japanese). ed 3. Tokyo, Kanehara Syuppan. 1999</mixed-citation><mixed-citation xml:lang="en">Japanese Urological Association, Japanese Society of Pathology, Japan-Radiological-Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma (in Japanese). ed 3. Tokyo, Kanehara Syuppan. 1999</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Acquired cysts and cancer of failing kidneys, Cancer and the Kidney, 2nd Ed, Cohen EP, Ed, Oxford University Press, in press. 2010</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Acquired cysts and cancer of failing kidneys, Cancer and the Kidney, 2nd Ed, Cohen EP, Ed, Oxford University Press, in press. 2010</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Japanese-Urological-Association: Clinical Practice Guideline for Renal Cell Carcinoma, 2007 ed (in Japanese), Tokyo, Kanehara Syuppan. 1-66, 2007</mixed-citation><mixed-citation xml:lang="en">Japanese-Urological-Association: Clinical Practice Guideline for Renal Cell Carcinoma, 2007 ed (in Japanese), Tokyo, Kanehara Syuppan. 1-66, 2007</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Terasawa Y, Hirota M, Sudo S: Detection of renal cell carcinoma detection by ultrasonography at health checkup (in Japanese). Japanese Association for Cancer Detection and Diagnosis 15: 166-171, 2008</mixed-citation><mixed-citation xml:lang="en">Terasawa Y, Hirota M, Sudo S: Detection of renal cell carcinoma detection by ultrasonography at health checkup (in Japanese). Japanese Association for Cancer Detection and Diagnosis 15: 166-171, 2008</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Marumo K, Satomi Y, Miyao N, Hasegawa M, Tomita Y, Igarashi T, Onishi T, Nakazawa H, Fukuda M, Ozono S, Terachi T, Tsushima T, Nakamoto T, Kawamura J: The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997. Int J Urol 8: 359-365, 2001</mixed-citation><mixed-citation xml:lang="en">Marumo K, Satomi Y, Miyao N, Hasegawa M, Tomita Y, Igarashi T, Onishi T, Nakazawa H, Fukuda M, Ozono S, Terachi T, Tsushima T, Nakamoto T, Kawamura J: The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997. Int J Urol 8: 359-365, 2001</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Saito Y, Nakamura M, Takada K, Ishii H, Nakazawa T, Fukuda Y, Asaka M, Tomosugi N, Yuri T: Fifteenyear follow-up of acquired renal cystic disease a gender difference. Nephron 75: 315-320, 1997</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Saito Y, Nakamura M, Takada K, Ishii H, Nakazawa T, Fukuda Y, Asaka M, Tomosugi N, Yuri T: Fifteenyear follow-up of acquired renal cystic disease a gender difference. Nephron 75: 315-320, 1997</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I, Honda R, Yamada Y, Kakuma T: Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial 8: 468-473, 2004</mixed-citation><mixed-citation xml:lang="en">Ishikawa I, Honda R, Yamada Y, Kakuma T: Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial 8: 468-473, 2004</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schwarz A, Vatandaslar S, Merkel S, Haller H: Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2: 750-756, 2007</mixed-citation><mixed-citation xml:lang="en">Schwarz A, Vatandaslar S, Merkel S, Haller H: Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2: 750-756, 2007</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Brown EA: Renal tumours in dialysis patients: who should we screen? Nephron Clin Pract 97: c3-4, 2004</mixed-citation><mixed-citation xml:lang="en">Brown EA: Renal tumours in dialysis patients: who should we screen? Nephron Clin Pract 97: c3-4, 2004</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sarasin FP, Wong JB, Levey AS, Meyer KB: Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int 48: 207-219, 1995</mixed-citation><mixed-citation xml:lang="en">Sarasin FP, Wong JB, Levey AS, Meyer KB: Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int 48: 207-219, 1995</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Scandling JD: Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol 2: 621-622, 2007</mixed-citation><mixed-citation xml:lang="en">Scandling JD: Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol 2: 621-622, 2007</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Uremic acquired renal cystic disease. Natural history and complications [editorial]. Nephron 58: 257-267, 1991</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Uremic acquired renal cystic disease. Natural history and complications [editorial]. Nephron 58: 257-267, 1991</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Takebayashi S, Hidai H, Chiba T, Takagi H, Koike S, Matsubara S: Using helical CT to evaluate renal cell carcinoma in patients undergoing hemodialysis: value of early enhanced images. Am. J. Roentgenol. 172: 429-433, 1999</mixed-citation><mixed-citation xml:lang="en">Takebayashi S, Hidai H, Chiba T, Takagi H, Koike S, Matsubara S: Using helical CT to evaluate renal cell carcinoma in patients undergoing hemodialysis: value of early enhanced images. Am. J. Roentgenol. 172: 429-433, 1999</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Akiyama T, Onoue A: Sonazoid-enhanced ultrasonography: adiagnosis of kidney and prostate disease (in Japanese). Innervision 22: 41-45, 2007</mixed-citation><mixed-citation xml:lang="en">Akiyama T, Onoue A: Sonazoid-enhanced ultrasonography: adiagnosis of kidney and prostate disease (in Japanese). Innervision 22: 41-45, 2007</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ak I, Can C: F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol 46: 895-899, 2005</mixed-citation><mixed-citation xml:lang="en">Ak I, Can C: F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol 46: 895-899, 2005</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, Ikemoto S, Inoue Y: Usefulness of F-18 FDGPET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma. Ann Nucl Med 21: 239-243, 2007</mixed-citation><mixed-citation xml:lang="en">Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, Ikemoto S, Inoue Y: Usefulness of F-18 FDGPET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma. Ann Nucl Med 21: 239-243, 2007</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Shinsako K, Mizuno T, Terada T, Watanabe J, Kamba T, Nakamura E, Ogawa O, Inui KI: Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study. Int J Clin Oncol, 2010</mixed-citation><mixed-citation xml:lang="en">Shinsako K, Mizuno T, Terada T, Watanabe J, Kamba T, Nakamura E, Ogawa O, Inui KI: Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study. Int J Clin Oncol, 2010</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa I: Cancer in dialysis patients. Cancer and the Kidney, Cohen EP, ed, Oxford University Press, Oxford: 227-247, 2005</mixed-citation><mixed-citation xml:lang="en">Ishikawa I: Cancer in dialysis patients. Cancer and the Kidney, Cohen EP, ed, Oxford University Press, Oxford: 227-247, 2005</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
